SAN DIEGO, Oct. 9, 2018 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) is the majority owner of a new subsidiary,Dalrada Health Products Corp, to become the marketing arm of the corporation. Dalrada Health Products Corp will partner with client companies for the distribution of medical disposables, hospital equipment & furniture, medical devices, laboratory
The Dalrada Health Products Corp is the second of new ventures that DFCO is creating. In June, the company announced Dalrada Precision, which will facilitate sales through previously established and new sales channels. Dalrada Precision will provide Management Services to other corporations by finding sourcing solutions.
Safe Harbor:Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
View original content:http://www.prnewswire.com/news-releases/dalrada-financial-establishes-new-subsidiary-300727338.html
SOURCE Dalrada Financial Corp.
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All